Abiopharma

🔍 Hargarten Christina (Executive)

Company: RH (RH)

Report Date: 2026-04-14

Detailed Transactions and Holdings:

• Acquired 7,500 shares of Stock Option (Right to Buy) at $130.72 per share (Derivative)
  Date: 2026-04-14 | Code: A | Expires: 2036-04-13 | equity_swap_involved: 0 | shares_owned_after: 7,500.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: This stock option award will vest and become exercisable over seven years as follows: 10% of the options will vest on each of the first, second and third anniversaries of the grant date, 15% of the options will vest on each of the fourth and fifth anniversaries of the grant date, and 20% of the options will vest on each of the sixth and seventh anniversaries of the grant date, subject to continuous service.